[1] Jimmy Donal Wales.Wikipekia(OnlineEncyclopaedia).Pharmacovigilance [EB/OL]. [2016-02-10].hppt://en.wikipedia.org/wiki/pharmcovigilance. [2] 刘巍,陈易新.药物警戒的概念和起源[J].中国执业药师,2008,5(7):16-18. [3] 崔燕宁.药物安全与药物警戒[M].北京:人民卫生出版社,2014:1-193. [4] 熊方武,李开顺,傅鹰.对“药物警戒的认知和探讨”[J].抗感染药学,2005,2(2):51-53. [5] 于培明,岳淑梅,李浩娜.药物警戒的理论与实践[J].药业纵横,2007,16(24):12-13. [6] 孙钰.药物警戒的起源、发展与展望[J].药物流行病学杂志,2010,19(8):455-460. [7] 施文.各国药物不良反应监测的发展和现状[N].医药经济报,2002-8-9(6). [8] Tsintis P,La Mache E.CIOMS and ICH initiatives in pharmacovigilance and risk management:overview and implications[J].Drug Saf,2004,27(8):509-517 [9] Rawlins M D, Fracchia G N, Rodriguez-Farré E. EURO-ADR:Pharmacovigilance and research.A European perspective[J]. Pharmacoepidemiology & Drug Safety, 1992,1(5):261-268. [10] Begaud B,Glossary. Methodological approaches in pharmacoepidemiology[M]. Amsterdam: Elsevier Science Publishers B.V.,1993:157-171. [11]杜勇.拓展药物警戒学有效交流国际会议及ERIC宣言[J].药物流行病学杂志,1998,7(1):1-3. [12] Meyboom R H B, EgbertS A C G, Gribnau F W J. et al. Pharmacovigilance in Perspective[J]. Drug saf, 1999,21(3): 429-447. [13] Mehta U, Milstien J B, Duclos P,et al.Developing a national system for dealing with adverse events following immunization[J]. Bulletin of the World Health Organization,2000,78(2):170-177. [14] Hartigan-Go K.Jimmy Donal Wales Pharmacovigilance and the pursuit of rational drug use[J].The Philippines Experience.Uppsala Reports,1996,14(2),356-358. [15] Springer Vienna. WHO collaborating centre for international drug monitoring[M]. Dictionary of Pharmaceutical Medicine,2009,1534(1):193-193. [16]眭萃,李国芬.CIOMS和ICH药物警戒指导原则及其对相关法规构建的影响[J].药物流行病学杂志,2010,19(9):524-525. [17]曾繁典.药物流行病学与药物警戒[J].药物流行病学杂志,2004,13(6):285-287. [18]曾繁典.我国药品风险管理与药物警戒实践[J].药物流行病学杂志,2013,22(3):140-142. [19] Meyboom R H B,Egberts A G G,Gribnay F W J,et al.Pharmacovigilance in Perspective[J].Drug SAF,1999,3(21):429-447. [20] Menta U,Milstien J B,Duclos P,et al.Developing a national system for dealing with adverse events following immuniztion[J].Bulletin of the world Healthe Organization,2000,78(2):170-177. [21] WHO. The Eric Report [C].International Conference on Developing Effective Communication in Pharmacovigilance.1997. [22] Edwards I R. The future of pharmacovigilance:a personal view[J].Eur J Clin Pharmacol,2008,64(2):173-181. |